AllianCat Ltd.

AllianCat is providing professional support to companies for business development and licensing. Licensing: Search, valuation, negotiation, drafting. Business development with quantitative market analyses and forecasts; evaluation and analyses of competitors, pipelines and sales potential; identification of the best positioned potential partner companies. Focus: pharmaceuticals, biotechnology.

Activity:

- Licensing & Business Development

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Cosmoceuticals
- Devices
- Diagnostics
- Drug delivery
- Generics
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Phyto
- Nutritionals / Vitamins
- Prescription drugs (Rx)
- Technology

Therapeutic targets:

- Aging
- AIDS
- Allergy
- Alzheimer's Disease
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Epidemiology
- Gastrointestinal
- Genetics
- Geriatrics
- Hematology
- Men's Health
- Mental Health
- Neurology
- Obesity
- Oncology
- Ophthalmology
- Orthopedics
- Pain
- Pediatrics
- Reproductive Health
- Respiratory Medicine
- Stroke
- Surgery
- Tonics
- Transplant
- Urology
- Women's Health

Markets Covered

a. HeadQuarter: Switzerland

b. Continent(s) active: Europe , Asia , North America

c. Countries active: Switzerland, Germany, France, UK, Scandinavia, Italy, Spain, Japan, Korea, Singapore, USA

Corporate data:

Number of Employees: 4

Turnover:

Amount:	Year:	Currency:
> 800000	2002	Euro

Year founded: 1998